Optimizing Dendritic Cell Preparation for Fusion with Melanoma Cells
(ندگان)پدیدآور
Li, YangZhang, LuWang, ShouyuShi, PengQu, Wei
نوع مدرک
TextOriginal Article
زبان مدرک
Englishچکیده
Background: Fusion of dendritic cells (DCs) with melanoma cells could reinforce the antigenicity of tumors as a strategy for the treatment of malignant melanoma. However, the insufficient quantity of DCs and the low fusion efficiency limits the development of such approach. Objective: To define the dosage of the stimulating factors as well as the induction condition for the optimal DCs preparation and cell fusion. Methods: DCs were generated from murine bone marrow cells, and cultured with four different concentrations of the granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). DCs were confirmed to be mature by detecting the expression of MHC-II, CD11c, CD80, and CD83 by flowcytometry. DCs-melanoma fusion cells were generated using polyethylene glycols (PEG) with different molecular weights and the fusion efficiency was detected by fluorescence-activated cell sorter (FACS). Results: The largest quantity of DCs was found when cells were cultured with 1000 U/ ml of GM-CSF and 500 U/ml of IL-4 (1.69 ± 0.04 ×10 6 ml-1, p the other three groups). The expression levels of MHC-II and CD83 on day 7 after incubation were significantly lower than those on day 3 (MHC-II: pConclusions: The largest quantity for mature DCs was stimulated with 1000 U/ml of GM-CSF and 500 U/ml of IL-4 and the highest fusion efficiency was under induction of PEG-3000.
کلید واژگان
Cell FusionDendritic cell
Melanoma
Polyethylene Glycol
شماره نشریه
3تاریخ نشر
2014-09-011393-06-10
ناشر
Shiraz Institute for Cancer Researchسازمان پدید آورنده
Department of OrthopaedicsDepartment of Maternity, First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning Province, China
Department of Orthopaedics
Department of Orthopaedics
Department of Orthopaedics
شاپا
1735-13831735-367X



